Alkermes (ALKS) Debt Ratio (2011 - 2026)
Alkermes' (ALKS) quarterly Debt Ratio came in at 0.35 in Q1 2026, up 164.69% on a QoQ basis from 0.13 in Q3 2024.
Alkermes (ALKS) Debt Ratio (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 15 years of Debt Ratio data on file, last reported at 0.35 in Q1 2026.
- On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.35 in Q1 2026; TTM through Mar 2026 was 0.35, a N/A change from a year earlier, with the FY2023 full-year figure at 0.14, down 8.86% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.35, up from 0.13 in the prior quarter.
- Over the last five years, Debt Ratio for ALKS reached as high as 0.35 in Q1 2026 and fell as low as 0.13 in Q3 2023.
- Historically, Debt Ratio has averaged 0.16 across 4 years, with a median of 0.14 in 2022.
- Across the five-year window, Debt Ratio dropped 15.54% in 2023 and climbed 4.83% in 2024, its largest moves.
- Year by year, Debt Ratio stood at 0.15 in 2022, then slipped by 8.86% to 0.14 in 2023, then retreated by 1.53% to 0.13 in 2024, then surged by 164.69% to 0.35 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.35 in Q1 2026, 0.13 in Q3 2024, and 0.13 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.26 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.42 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.29 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 0.10 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.29 |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.35 |
| Sep 30, 2024 | 0.13 |
| Jun 30, 2024 | 0.13 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.14 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.15 |
| Sep 30, 2022 | 0.15 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.15 |
| Jun 30, 2021 | 0.15 |
| Mar 31, 2021 | 0.16 |
| Dec 31, 2020 | 0.14 |
| Sep 30, 2020 | 0.15 |
| Jun 30, 2020 | 0.15 |
| Mar 31, 2020 | 0.15 |